Review: Stem Cell Based Therapy-in COVID-19

ABSTRACT

On 2019 December, the first COVID-19 patient was detected in Wuhan, China. Currently, the world is still facing the pandemic. The novel virusis associated with pneumonia. Coronaviruses are RNA single-stranded viruses. They are enveloped. This notorious virus is classified into alpha (cause asymptomatic infections), beta,gamma and delta coronaviruses (subfamilies). The doctors use corticosteroids and antibiotics to reduce inflammation of various secondary bacterial infections. Mesenchymal stem cell (MSCs) can be used in the treatment of this virus because of their multipotent characteristic as well as their characteristic plasticity. In this paper we try to analyse the treatment for covid-19 with the help of characteristic feature of plasticity of stem cells including its multipotent character. The reason for this article is to survey the proof for the alternative treatment of SARS CoV-2 with the help of stem cell based theory.